 | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
| Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
Insider Trading - Regulus Therapeutics Inc. (RGLS)
| | "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> SPAC List: List of Special Purpose Acquisition Companies |
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2020-12-04 Purchase | 2020-12-07 5:08 pm | Regulus Therapeutics Inc. | RGLS | BASKETT FOREST 10% Owner | 4,398,602 | $0.622 | $2,735,930 | 6,451,056 (Indirect) | View |
| 2020-12-04 Purchase | 2020-12-07 5:09 pm | Regulus Therapeutics Inc. | RGLS | Behbahani Ali 10% Owner | 4,398,602 | $0.622 | $2,735,930 | 6,451,056 (Indirect) | View |
| 2020-12-04 Purchase | 2020-12-07 5:10 pm | Regulus Therapeutics Inc. | RGLS | Chang Carmen 10% Owner | 4,398,602 | $0.622 | $2,735,930 | 6,451,056 (Indirect) | View |
| 2020-12-04 Purchase | 2020-12-07 5:10 pm | Regulus Therapeutics Inc. | RGLS | Florence Anthony A. Jr. 10% Owner | 4,398,602 | $0.622 | $2,735,930 | 6,451,056 (Indirect) | View |
| 2020-12-04 Purchase | 2020-12-07 5:11 pm | Regulus Therapeutics Inc. | RGLS | Makhzoumi Mohamad 10% Owner | 4,398,602 | $0.622 | $2,735,930 | 6,451,056 (Indirect) | View |
| 2020-12-04 Purchase | 2020-12-07 5:12 pm | Regulus Therapeutics Inc. | RGLS | MAKOWER JOSHUA 10% Owner | 4,398,602 | $0.622 | $2,735,930 | 6,451,056 (Indirect) | View |
| 2020-12-04 Purchase | 2020-12-07 5:12 pm | Regulus Therapeutics Inc. | RGLS | SANDELL SCOTT D 10% Owner | 4,398,602 | $0.622 | $2,735,930 | 6,451,056 (Indirect) | View |
| 2020-12-04 Purchase | 2020-12-07 5:13 pm | Regulus Therapeutics Inc. | RGLS | Sonsini Peter W. 10% Owner | 4,398,602 | $0.622 | $2,735,930 | 6,451,056 (Indirect) | View |
| 2020-12-04 Purchase | 2020-12-07 5:14 pm | Regulus Therapeutics Inc. | RGLS | Walker Paul Edward 10% Owner | 4,398,602 | $0.622 | $2,735,930 | 6,451,056 (Indirect) | View |
| 2021-02-16 Sale | 2021-02-17 5:23 pm | Regulus Therapeutics Inc. | RGLS | Hagan Joseph P CEO | 4,144 | $1.72 | $7,128 | 485,756 (Direct) | View |
| 2021-02-16 Sale | 2021-02-17 5:23 pm | Regulus Therapeutics Inc. | RGLS | Aker Christopher Ray VP | 828 | $1.72 | $1,424 | 42,614 (Direct) | View |
| 2021-02-16 Sale(A) | 2021-04-16 4:11 pm | Regulus Therapeutics Inc. | RGLS | Hagan Joseph P CEO | 4,144 | $1.72 | $7,128 | 244,628 (Direct) | View |
| 2021-05-17 Sale | 2021-05-17 7:12 pm | Regulus Therapeutics Inc. | RGLS | Aker Christopher Ray VP | 860 | $0.89 | $765 | 41,754 (Direct) | View |
| 2021-05-17 Sale | 2021-05-17 7:13 pm | Regulus Therapeutics Inc. | RGLS | Hagan Joseph P CEO | 4,186 | $0.89 | $3,726 | 316,292 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2020-12-04 Purchase | 2020-12-07 5:08 pm | 2020-12-04 2025-12-04 | Regulus Therapeutics Inc. | RGLS | BASKETT FOREST 10% Owner | 5,239,254 | $0.125 | 5,239,254 (Indirect) | View |
| 2020-12-04 Purchase | 2020-12-07 5:08 pm | 2020-12-04 N/A | Regulus Therapeutics Inc. | RGLS | BASKETT FOREST 10% Owner | 258,707 | $6.22 | 258,707 (Indirect) | View |
| 2020-12-04 Purchase | 2020-12-07 5:09 pm | 2020-12-04 2025-12-04 | Regulus Therapeutics Inc. | RGLS | Behbahani Ali 10% Owner | 5,239,254 | $0.125 | 5,239,254 (Indirect) | View |
| 2020-12-04 Purchase | 2020-12-07 5:09 pm | 2020-12-04 N/A | Regulus Therapeutics Inc. | RGLS | Behbahani Ali 10% Owner | 258,707 | $6.22 | 258,707 (Indirect) | View |
| 2020-12-04 Purchase | 2020-12-07 5:10 pm | 2020-12-04 2025-12-04 | Regulus Therapeutics Inc. | RGLS | Chang Carmen 10% Owner | 5,239,254 | $0.125 | 5,239,254 (Indirect) | View |
| 2020-12-04 Purchase | 2020-12-07 5:10 pm | 2020-12-04 N/A | Regulus Therapeutics Inc. | RGLS | Chang Carmen 10% Owner | 258,707 | $6.22 | 258,707 (Indirect) | View |
| 2020-12-04 Purchase | 2020-12-07 5:10 pm | 2020-12-04 2025-12-04 | Regulus Therapeutics Inc. | RGLS | Florence Anthony A. Jr. 10% Owner | 5,239,254 | $0.125 | 5,239,254 (Indirect) | View |
| 2020-12-04 Purchase | 2020-12-07 5:10 pm | 2020-12-04 N/A | Regulus Therapeutics Inc. | RGLS | Florence Anthony A. Jr. 10% Owner | 258,707 | $6.22 | 258,707 (Indirect) | View |
| 2020-12-04 Purchase | 2020-12-07 5:11 pm | 2020-12-04 2025-12-04 | Regulus Therapeutics Inc. | RGLS | Makhzoumi Mohamad 10% Owner | 5,239,254 | $0.125 | 5,239,254 (Indirect) | View |
| 2020-12-04 Purchase | 2020-12-07 5:11 pm | 2020-12-04 N/A | Regulus Therapeutics Inc. | RGLS | Makhzoumi Mohamad 10% Owner | 258,707 | $6.22 | 258,707 (Indirect) | View |
| 2020-12-04 Purchase | 2020-12-07 5:12 pm | 2020-12-04 2025-12-04 | Regulus Therapeutics Inc. | RGLS | MAKOWER JOSHUA 10% Owner | 5,239,254 | $0.125 | 5,239,254 (Indirect) | View |
| 2020-12-04 Purchase | 2020-12-07 5:12 pm | 2020-12-04 N/A | Regulus Therapeutics Inc. | RGLS | MAKOWER JOSHUA 10% Owner | 258,707 | $6.22 | 258,707 (Indirect) | View |
| 2020-12-04 Purchase | 2020-12-07 5:12 pm | 2020-12-04 2025-12-04 | Regulus Therapeutics Inc. | RGLS | SANDELL SCOTT D 10% Owner | 5,239,254 | $0.125 | 5,239,254 (Indirect) | View |
| 2020-12-04 Purchase | 2020-12-07 5:12 pm | 2020-12-04 N/A | Regulus Therapeutics Inc. | RGLS | SANDELL SCOTT D 10% Owner | 258,707 | $6.22 | 258,707 (Indirect) | View |
| 2020-12-04 Purchase | 2020-12-07 5:13 pm | 2020-12-04 2025-12-04 | Regulus Therapeutics Inc. | RGLS | Sonsini Peter W. 10% Owner | 5,239,254 | $0.125 | 5,239,254 (Indirect) | View |
| 2020-12-04 Purchase | 2020-12-07 5:13 pm | 2020-12-04 N/A | Regulus Therapeutics Inc. | RGLS | Sonsini Peter W. 10% Owner | 258,707 | $6.22 | 258,707 (Indirect) | View |
| 2020-12-04 Purchase | 2020-12-07 5:14 pm | 2020-12-04 2025-12-04 | Regulus Therapeutics Inc. | RGLS | Walker Paul Edward 10% Owner | 5,239,254 | $0.125 | 5,239,254 (Indirect) | View |
| 2020-12-04 Purchase | 2020-12-07 5:14 pm | 2020-12-04 N/A | Regulus Therapeutics Inc. | RGLS | Walker Paul Edward 10% Owner | 258,707 | $6.22 | 258,707 (Indirect) | View |
| 2020-12-04 Option Award | 2021-01-27 8:16 pm | N/A N/A | Regulus Therapeutics Inc. | RGLS | PAPADOPOULOS STELIOS Director | 793,528 | $0.6301 | 2,839,707 (Direct) | View |
| 2021-01-06 Option Award | 2021-01-27 8:32 pm | N/A 2031-01-26 | Regulus Therapeutics Inc. | RGLS | Huang Alice Shih-hou BALTIMORE DAVID Director | 80,000 | $0 | 80,000 (Direct) | View |
| 2021-02-04 Option Award | 2021-02-05 4:57 pm | N/A 2031-02-04 | Regulus Therapeutics Inc. | RGLS | Aker Christopher Ray VP | 180,000 | $0 | 180,000 (Direct) | View |
| 2021-02-04 Option Award | 2021-02-05 4:58 pm | N/A 2031-02-04 | Regulus Therapeutics Inc. | RGLS | CALSADA CRISPINA CFO | 150,000 | $0 | 150,000 (Direct) | View |
| 2021-02-04 Option Award | 2021-02-05 5:00 pm | N/A 2031-02-04 | Regulus Therapeutics Inc. | RGLS | Drygin Denis Chief Scientific Officer | 120,000 | $0 | 120,000 (Direct) | View |
| 2021-02-04 Option Award | 2021-02-05 5:01 pm | N/A 2031-02-04 | Regulus Therapeutics Inc. | RGLS | Hagan Joseph P CEO | 600,000 | $0 | 600,000 (Direct) | View |
| 2021-04-14 Conversion | 2021-04-16 4:12 pm | N/A N/A | Regulus Therapeutics Inc. | RGLS | Hagan Joseph P CEO | 75,850 | $0 | 320,478 (Direct) | View |
| 2021-04-14 Conversion | 2021-04-16 4:12 pm | N/A N/A | Regulus Therapeutics Inc. | RGLS | Hagan Joseph P CEO | 7,585 | $0 | 0 (Indirect) | View |
| 2021-06-14 Option Award | 2021-06-15 4:39 pm | N/A 2031-06-13 | Regulus Therapeutics Inc. | RGLS | BALTIMORE DAVID Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2021-06-14 Option Award | 2021-06-15 4:40 pm | N/A 2031-06-13 | Regulus Therapeutics Inc. | RGLS | Collier Kathryn J Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2021-06-14 Option Award | 2021-06-15 4:42 pm | N/A 2031-06-13 | Regulus Therapeutics Inc. | RGLS | Huang Alice Shih-hou Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2021-06-14 Option Award | 2021-06-15 4:43 pm | N/A 2031-06-13 | Regulus Therapeutics Inc. | RGLS | Nunn Jason Raleigh Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2021-06-14 Option Award | 2021-06-15 4:43 pm | N/A 2031-06-13 | Regulus Therapeutics Inc. | RGLS | PAPADOPOULOS STELIOS Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2021-06-14 Option Award | 2021-06-15 4:44 pm | N/A 2031-06-13 | Regulus Therapeutics Inc. | RGLS | RASTETTER WILLIAM H Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2021-06-14 Option Award | 2021-06-15 4:45 pm | N/A 2031-06-13 | Regulus Therapeutics Inc. | RGLS | Rosen Hugh Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2021-06-14 Option Award | 2021-06-15 4:46 pm | N/A 2031-06-13 | Regulus Therapeutics Inc. | RGLS | Witz Pascale Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2021-06-14 Option Award | 2021-06-15 5:17 pm | N/A 2031-06-13 | Regulus Therapeutics Inc. | RGLS | Simeonidis Simos Director | 40,000 | $0 | 40,000 (Direct) | View |